miRNA‑125a modulates autophagy of thyroiditis through PI3K/Akt/mTOR signaling pathway
Authors:
Open Access
- 12 February 2019
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 17 (4) , 2465-2472
Abstract
The present study examined the potential function and underlying mechanisms of microRNA‑125a (miR‑125a) in thyroiditis. Mice were subcutaneously administered with 100 µg porcine thyroglobulin weekly for 2 weeks to establish the thyroiditis model. Results of the in vivo study demonstrated that miR‑125a serum expression was upregulated in thyroiditis mice compared with the control group. In vitro studies were performed on a mouse macrophage cell line in which a model of thyroiditis was established using 10 ng/ml human interferon‑γ. Upregulated miR‑125a expression was achieved via mimic transfection. Increased miR‑125a expression reduced autophagy and cell proliferation, increased the apoptotic rate and the expression of pro‑inflammatory factors tumor necrosis factor‑α, interleukin (IL)‑1β, IL‑6 and IL‑18 via downregulation of the phosphoinositide 3‑kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway. PI3K inhibition enhanced the ability of miR‑125a to increase the inflammatory response in vitro via regulation of the PI3K/Akt/mTOR signaling pathway. These results suggest miR‑125a inhibited autophagy in a model of thyroiditis through the PI3K/Akt/mTOR signaling pathway.Keywords
This publication has 27 references indexed in Scilit:
- MicroRNA-125a Inhibits Autophagy Activation and Antimicrobial Responses during Mycobacterial InfectionThe Journal of Immunology, 2015
- Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish populationImmunobiology, 2014
- Follicular Thyroid Cancers Demonstrate Dual Activation of PKA and mTOR as Modeled by Thyroid-Specific Deletion of Prkar1a and Pten in MiceThe Journal of Clinical Endocrinology & Metabolism, 2014
- The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trialTrials, 2014
- Self-Reported Autoimmune Disease by Sex in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyDiabetes Care, 2014
- Thyroid hydrogen peroxide production is enhanced by the Th2 cytokines, IL-4 and IL-13, through increased expression of the dual oxidase 2and its maturation factorDUOXA2Free Radical Biology and Medicine, 2013
- Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trialLasers in Medical Science, 2012
- The mTOR protein as a target in thyroid cancerExpert Opinion on Therapeutic Targets, 2011
- Autophagy Induction with RAD001 Enhances Chemosensitivity and Radiosensitivity through Met Inhibition in Papillary Thyroid CancerMolecular Cancer Research, 2010
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001